Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Mannitol vs hypertonic saline for intracranial pressure after large hemispheric infarction
ChiCTR-IPR-17010545Phase 4Recruiting
- Sponsor
- Xuanwu Hospital
- Start
- Jan 2017
- Modality
- Small Molecules, Inhalation Devices → Device-based Delivery → Drug Delivery Systems
- Countries
- 1
01
Overview
Phase 4, randomised trial of Bronchitol and hypertonic saline in brain infarction (2 arms), sponsored by Xuanwu Hospital. Primary endpoints: intracranial pressure and pupil. Started Jan 2017; status: recruiting.
02
Drugs
Bronchitolhypertonic saline
03
Conditions
brain infarction
Beyond the preview
Go deeper on ChiCTR-IPR-17010545.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR-IPR-17010545.